Innovital, Llc

What Innovital, Llc does

CLR Medical, operating as Innovital, LLC, is a U.S. medical device company that has developed a patented closed-system platform for thoracic irrigation through indwelling catheters. Founded in 2021 and headquartered in Beltsville, Maryland, the company targets the problem of retained hemothorax and complicated pleural collections with three integrated sterile products: the CLR Irrigator (an ergonomic suction/irrigator enabling one-handed toggling between suction and irrigation), the CLR Port (an indwelling access point that maintains suction-circuit integrity during repeated or delayed lavage), and the CLR Port Injector (a Luer-compatible accessory for pleural fluid sampling and intrapleural fibrinolytic therapy). The platform is protected by two granted U.S. patents (#10,596,312 and #11,103,623) with additional applications pending, and integrates with existing chest drainage systems such as Pleur-Evac and standard 24 Fr+ chest tubes and pigtail catheters.

The company sells directly to hospitals in the United States through an enterprise field-sales motion focused on Level 1 trauma centers, ICU teams, and pulmonology departments. Rather than transactional device placement, the GTM emphasizes hospital-wide protocol adoption across trauma surgeons, emergency physicians, advanced practice providers, nurses, clinical educators, supply chain, and hospital leadership. Pricing is not publicly disclosed and is negotiated per hospital contract. Revenue is generated through hardware sales of sterile medical devices shipped directly to customer hospitals.

CLR Medical's commercial position is anchored by a decade-plus clinical evidence base — including prospective observational studies at 11 centers (493 hemithoraces), 17-center and 29-center international cohorts, and Medical College of Wisconsin's 5-year outcomes series — supporting outcomes such as a 44-80% reduction in odds of secondary intervention, ~3 fewer hospital days, and roughly $88,000-$90,000 in mean cost savings per patient. Key clinical relationships include Orlando Regional Medical Center (reference implementation), Medical College of Wisconsin (long-term outcomes), and inclusion of CLR-enabled thoracic irrigation in the Western Trauma Association's hemothorax management algorithm. Leadership comprises President Gregory Hiemenz, Ph.D., Chief Medical Officer Amit Shah, M.D., and Clinical Educator Miranda Miller, BSN, RN.

Name

Innovital, Llc

Legal name

Innovital, LLC

Website

https://clrmedical.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

CLR Medical (Innovital, LLC) is a U.S. medical device company that sells a patented closed-system thoracic irrigation platform — CLR Irrigator, CLR Port, and CLR Port Injector — directly to Level 1 trauma centers and hospitals for management of hemothorax and pleural collections.

Ownership category

akta.pro rank

Product category

Thoracic irrigation medical devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Suction, Irrigation & Fluid Management Systems (HLAHADAK)

Keywords

• Thoracic irrigation devices
• Hemothorax management systems
• Pleural drainage catheters
• Trauma care medical devices
• Closed-system lavage

Headquarters

HQ city

Beltsville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Medical Device Sales: CLR Medical generates revenue through the sale of its thoracic irrigation device platform, including the CLR Irrigator, CLR Port, and CLR Port Injector. These are sterile medical devices shipped to hospitals for use in trauma, ICU, OR, and procedure settings. The company sells directly to hospital systems with a consultative implementation approach focused on protocol adoption.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

CLR Medical (Innovital, LLC) develops and sells the CLR closed-system thoracic irrigation platform, comprising the CLR Irrigator, CLR Port, and CLR Port Injector. These sterile medical devices are sold directly to hospitals for managing hemothorax, pleural effusions, and complicated pleural infections through indwelling chest tubes and pigtail catheters, enabling one-handed irrigation and suction without breaking the suction circuit.

Product overview

CLR Medical offers a device platform for CLR-enabled thoracic irrigation comprising three distinct products: the CLR Irrigator (core product - ergonomic suction/irrigator), the CLR Port (accessory port for repeated irrigation), and the CLR Port Injector (accessory for syringe access). These products work together as a closed-system solution for thoracic irrigation through indwelling catheters (chest tubes and pigtail catheters 24 Fr and larger), enabling healthcare providers to perform irrigation and suction with one-handed operation while maintaining connection to standard chest drainage systems.

Differentiator

Problem solved

Functional benefit

Brands

• CLR Irrigator: Patented ergonomic suction/irrigator enabling one-handed thoracic lavage through chest tubes and pigtail catheters
• CLR Port
• CLR Port Injector

Products and services

• CLR Irrigator A patented, ergonomic suction/irrigator device that enables one-handed thoracic irrigation and suction through indwelling catheters such as chest tubes and pigtail catheters. Features color-coded buttons (blue for irrigation, red for suction), high-flow-rate bag spike for standard fluid bags, and adaptable nozzle connecting to wide-range catheters (24 Fr and larger). Sold to hospitals for use in trauma, ICU, OR, and procedure settings.
• CLR Port An accessory port device that stays attached to indwelling catheters, allowing standard drainage as well as sterile access for repeated or delayed irrigation without breaking the suction circuit. Connects to catheters 24 Fr and larger, features a twist-lock Access Cap, and provides automatic shutoff when the CLR Irrigator is docked, sealing the connection to the drainage system.
• CLR Port Injector An accessory device that enables Luer syringes to connect to the CLR Port for pleural fluid sampling or intrapleural fibrinolytic therapy protocols without breaking the suction circuit. Used in hospitals for thoracic irrigation and pleural management workflows.

Quantifiable outcome

• 44% decrease in odds of requiring secondary intervention for retained hemothorax (p=0.005) in 11-center prospective study of 493 hemithoraces
• +8 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Orlando Regional Medical CentercoreStrategic or Co-development PartnerORMC has incorporated CLR-enabled thoracic irrigation into its standard hemothorax management algorithm, serving as a reference implementation for other hospitals. The center's retained hemothorax management protocol (developed in collaboration with surgical critical care guidelines) is cited by CLR Medical as a useful starting reference for other trauma programs adopting the practice.
• Western Trauma AssociationcoreStrategic or Co-development PartnerThoracic irrigation using CLR devices is incorporated into the Western Trauma Association's hemothorax management algorithm, establishing the practice as guideline-supported care within the trauma surgery community.
• Medical College of WisconsincoreStrategic or Co-development PartnerMCW has published their 5-year experience with thoracic irrigation demonstrating significant outcomes including 50-75%+ reduction in retained hemothorax with early irrigation. Their clinical data and protocol serve as evidence for broader adoption of CLR-enabled irrigation.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Cook Medical: Cook Medical manufactures a range of interventional catheters including chest drainage and pigtail catheters that are directly compatible with the CLR Port. It competes for the same thoracic interventional procedure budget and is a natural strategic acquirer of catheter-based accessory platforms.
• Getinge (Atrium Medical): Getinge's Atrium subsidiary manufactures chest drainage catheters and systems used in trauma and cardiothoracic surgery. It competes for the same hospital chest-tube and drainage procedure budget and is a logical OEM partner or acquirer for a thoracic irrigation accessory platform.
• Teleflex: Teleflex markets the Pleur-Evac chest drainage system, which is explicitly listed as an integration partner for the CLR platform. As the incumbent supplier of the drainage canisters that CLR connects to, Teleflex is the most directly comparable peer and the most likely strategic acquirer given portfolio adjacency.
• Vygon: Vygon manufactures single-use interventional and drainage catheters used in thoracic and pleural procedures. It is a direct peer competing in catheter-based pleural drainage and is a plausible OEM partner or acquirer of a catheter accessory platform.
• Smiths Medical: Smiths Medical (now ICU Medical) produces chest drainage systems, catheters, and acute care disposables used in trauma and ICU settings. It is comparable as a direct peer selling into the same hospital thoracic procedure workflow.

Emerging players

• AtriCure: AtriCure is a specialty surgical device company focused on cardiac and thoracic procedures. It is comparable as an emerging-to-mid-stage surgical device player targeting the same cardiothoracic and trauma surgery specialists who adopt thoracic irrigation protocols.

Broad incumbents

• Medtronic: Medtronic is a large diversified medical device company with surgical and respiratory portfolios that overlap with thoracic procedures and chest drainage. It is comparable as a broad incumbent whose hospital relationships and salesforce CLR must sell against or partner with.
• Stryker: Stryker is a large diversified medical device company with surgical, emergency, and acute care portfolios that overlap with trauma and ICU customer segments. It is comparable as a broad incumbent whose hospital relationships and trauma product portfolio are adjacent to CLR's market.
• B. Braun: B. Braun is a large medical device and IV therapy company with hospital sales channels that overlap with CLR's trauma and ICU customer base. It is comparable as a broad incumbent with hospital procurement leverage in the same procedure categories.
• Becton Dickinson (BD): BD sells a broad portfolio of medical devices and disposables to hospitals, including surgical instruments and infection-prevention products. It is comparable as a large incumbent with established hospital contracts and GPO relationships relevant to CLR's enterprise selling motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/CLRMedical
• LinkedInlinkedin.com/company/clrmedical

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovital, Llc